Prot#LTI-301: A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients

Project: Research project

Project Details

StatusActive
Effective start/end date1/24/181/24/21

Funding

  • Nuventra, Inc. (Prot#LTI-301)
  • Liquidia Technologies, Inc. (Prot#LTI-301)